Skip to main content
NCBI home page
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1980 Oct;56(5):332–336. doi: 10.1136/sti.56.5.332

Tetracycline in nongonococcal urethritis. Comparison of 2 g and 1 g daily for seven days.

W R Bowie, J S Yu, A Fawcett, H D Jones
PMCID: PMC1045819  PMID: 7427705

Abstract

In a previous study treatment with minocycline 100 mg orally every day for seven days was as effective for nongonococcal urethritis (NGU) as 200 mg for seven days or 100 or 200 mg for 21 days. In this prospective, randomised study men with NGU received tetracycline either 500 mg or 250 mg four times daily for seven days. of 200 men initially enrolled, Chlamydia trachomatis was isolated from 40% and Ureaplasma urealyticum from 48%. Eight of 10 homosexual men compared with 39 (21%) of 190 bisexual or heterosexual men had negative culture results for both C trachomatis and U urealyticum (x2 = 15.5, P < 0.0005). U urealyticum was isolated more frequently from chlamydia-negative men and from men with 10 or fewer sex partners during their lifetime. Both regimens were equally effective in their in-vivo activity against C trachomatis and U urealyticum. Failure rates were similar with the two regimens. More obvious failure with purulent or profuse mucoid discharge and pyuria occurred more frequently with the 250-mg regimen (20% of 76 men on the 250-mg regimen compared with 7% of 67 men on the 500-mg regimen; x2 = 4.45, P < 0.05). Failure occurred more frequently in men who were initially chlamydia-negative and in men in whom U urealyticum persisted after medication. Thus, the 250-mg regimen appeared to be as effective as the 500-mg regimen in the initial treatment of NGU. However, one-third of men had persistent or recurrent urethritis with these regimens, and there is a need for antimicrobial agents with greater in-vivo activity, especially against chlamydia-negative NGU.

Full text

PDF
332

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowie W. R., Digiacomo R. F., Holmes K. K., Gale J. L. Genital inoculation of male Macaca fascicularis with Neisseria gonorrhoeae and Ureaplasma urealyticum. Br J Vener Dis. 1978 Aug;54(4):235–238. doi: 10.1136/sti.54.4.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bowie W. R. Etiology and treatment of nongonococcal urethritis. Sex Transm Dis. 1978 Jan-Mar;5(1):27–33. doi: 10.1097/00007435-197801000-00009. [DOI] [PubMed] [Google Scholar]
  3. Bowie W. R., Floyd J. F., Miller Y., Alexander E. R., Holmes J., Holmes K. K. Differential response of chlamydial and ureaplasma-associated urethritis to sulphafurazole (sulfisoxazole) and aminocyclitols. Lancet. 1976 Dec 11;2(7998):1276–1278. doi: 10.1016/s0140-6736(76)92034-1. [DOI] [PubMed] [Google Scholar]
  4. Bowie W. R., Wang S. P., Alexander E. R., Floyd J., Forsyth P. S., Pollock H. M., Lin J. S., Buchanan T. M., Holmes K. K. Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest. 1977 May;59(5):735–742. doi: 10.1172/JCI108694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coufalik E. D., Taylor-Robinson D., Csonka G. W. Treatment of nongonococcal urethritis with rifampicin as a means of defining the role of Ureaplasma urealyticum. Br J Vener Dis. 1979 Feb;55(1):36–43. doi: 10.1136/sti.55.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Handsfield H. H., Alexander E. R., Pin Wang S., Pedersen A. H., Holmes K. K. Differences in the therapeutic response of chlamydia-positive and chlamydia-negative forms of nongonococcal urethritis. J Am Vener Dis Assoc. 1976 Mar;2(3):5–9. [PubMed] [Google Scholar]
  7. Robertson J. A. Bromothymol blue broth: improved medium for detection of Ureaplasma urealyticum (T-strain mycoplasma). J Clin Microbiol. 1978 Feb;7(2):127–132. doi: 10.1128/jcm.7.2.127-132.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Tarr P. I., Lee Y. H., Alpert S., Schumacher J. R., Zinner S. H., McCormack W. M. Comparison of methods for the isolation of genital mycoplasmas from men. J Infect Dis. 1976 Apr;133(4):419–423. doi: 10.1093/infdis/133.4.419. [DOI] [PubMed] [Google Scholar]
  9. Taylor-Robinson D., Csonka G. W., Prentice M. J. Human intra-urethral inoculation of ureplasmas. Q J Med. 1977 Jul;46(183):309–326. [PubMed] [Google Scholar]
  10. Thambar I. V., Simmons P. D., Thin R. N., Darougar S., Yearsley P. Double-blind comparison of two regimens in the treatment of nongonococcal urethritis. Seven-day vs 21-day course of triple tetracyclinc (Deteclo). Br J Vener Dis. 1979 Aug;55(4):284–288. doi: 10.1136/sti.55.4.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wentworth B. B., Alexander E. R. Isolation of Chlamydia trachomatis by use of 5-iodo-2-deoxyuridine-treated cells. Appl Microbiol. 1974 May;27(5):912–916. doi: 10.1128/am.27.5.912-916.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wong J. L., Hines P. A., Brasher M. D., Rogers G. T., Smith R. F., Schachter J. The etiology of nongonococcal urethritis in men attending a venereal disease clinic. Sex Transm Dis. 1977 Jan-Mar;4(1):4–8. doi: 10.1097/00007435-197701000-00002. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES